Background
==========

Breast cancer is one of the tumors with the most effective therapies in clinical practice, in which metastasis and recurrence are major causes of death, and the pathological staging is significantly correlated with secondary metastasis \[[@b1-medscimonit-24-8553]\]. Although invasive breast cancer (IBC) has been one of the focuses of tumor research in recent years, the variety of differentially expressed genes (DEGs) in IBC makes the research very complicated and the molecular mechanism and metastasis pathway are still unknown. Therefore, it is of particular importance to determine the core gene involved in cell proliferation, migration, and invasion, and to study its effect on drug susceptibility to neoadjuvant chemotherapy in IBC.

Many cancer-related genes can be identified by bioinformatic methods before they are experimentally and clinically validated. In the study of breast cancer, DEGs in normal and cancer tissues can be screened by using the Gene Expression Omnibus (GEO) and STRING database or by GSEA and meta-analysis. Then, the key genes related to breast cancer are identified by comparing the structure and function of breast cancer-associated genes in NCBI data. For instance, Zhou et al. screened candidate genes that may be involved in the molecular mechanisms of breast cancer, including previously reported genes FOS \[[@b2-medscimonit-24-8553]\] and IL18 \[[@b3-medscimonit-24-8553]\], and new genes that have not been studied, including MYC, ACTA2, and CD274. Nucleolar and spindle associated protein 1 (NUSAP1) can control the cell cycle by promoting the aggregation of microtubules, which play a crucial role in spindle assembly and formation. The protein expression of NUSAP1 changes periodically in the course of the cell cycle, accumulating in interkinesis and decreasing after mitosis \[[@b4-medscimonit-24-8553]\]. There are extensive studies of the NUSAP1 gene in various tumors, and previous studies have shown that high expression of NUSAP1 can serve as a prognostic factor in breast cancer \[[@b5-medscimonit-24-8553]\], liver cancer \[[@b6-medscimonit-24-8553]\], prostate cancer \[[@b7-medscimonit-24-8553]\], pancreatic cancer \[[@b8-medscimonit-24-8553]\], oral squamous carcinoma \[[@b9-medscimonit-24-8553]\], melanoma \[[@b10-medscimonit-24-8553],[@b11-medscimonit-24-8553]\], and glioblastoma \[[@b12-medscimonit-24-8553]\]. However, the role of NUSAP1 in IBC has not yet been reported.

In this study, the IBC-related gene NUSAP1 was screened by bioinformatics method. The protein interactions between NUSAP1 and CDK1/DLGAP1 were predicted by STRING database (*<http://string.embl.de/>*). We found that downregulation of NUSAP1 expression downregulated the expression of CDK1 and DLGAP1, as well as inhibiting proliferation, migration, and invasion of IBC cells and increasing the susceptibility of cells to epirubicin (E-ADM).

Material and Methods
====================

Gene chip data processing
-------------------------

The data set GSE21974 was obtained from the Gene Expression Omnibus (GEO) (*<http://www.nebi.nlm.nih.gov/geo>*) with "invasive breast cancer" and/or "neoadjuvant chemotherapy" as the key words. The chip platform was Agilent-014850 Whole Human Genome Microarray 4×44k G4112F (GPL 6480). GSE21974 included 57 samples (32 invasive breast cancer samples before treatment and 25 invasive breast cancer samples after treatment). GSE21422 was obtained from the Gene Expression Omnibus (GEO) with "Human healthy tissue samples" and "DCIS and invasive mammary tumors" as key words.

PolySearch 2.0 database and network analysis
--------------------------------------------

IBC-related genes were searched in PolySearch 2.0 (*<http://polysearch.cs.ualberta.ca/>*) with "invasive breast cancer" as the key words. PPI network diagram was established using diagnostic tools of STRING.

Collection of clinical specimens
--------------------------------

Forty-five IBC patients who underwent radical mastectomy and neoadjuvant chemotherapy were selected in Xiangya Hospital. Inclusion criteria were: etiological diagnosis before chemotherapy, indication for radical resection and neoadjuvant chemotherapy, and signed informed consent. Exclusion criteria were: incomplete clinical data, serious organ diseases, lactation and pregnancy, and untreated patients.

Cell culture
------------

IBC cell line IOWA-1T (ATCC^®^ CRL-3292™) was purchased from the ATCC cell bank. Breast cancer cell lines MDA-MB-231, T47D, and MCF-7 and healthy mammary fibroblasts Hs578Bst were purchased from the Shanghai Cell Bank. Cells were cultured in 5% CO~2~ at 37°C in Dulbecco's modified Eagle's medium/F-12 HAM (Sigma-Aldrich Chemical Company, St. Louis, MO, USA) supplemented with 50 units/ml penicillin-streptomycin (Sigma-Aldrich Chemical Company, St. Louis, MO, USA) and 10% fetal bovine serum (FBS; Sigma-Aldrich Chemical Company, St. Louis, MO, USA).

Total RNA extraction and quantitative polymerase chain reaction (q-PCR)
-----------------------------------------------------------------------

Total RNA was extracted using the TRIzol extraction kit (Invitrogen Life Technologies, Carlsbad, CA, USA). Using Ready-To-Go You-Prime First-Strand Beads (GE Healthcare, Buckinghamshire, UK), reverse transcription was conducted to obtain cDNA from 5 ug total RNA. NUSAP1 mRNA expression was examined by using the LightCycler 480 PCR system (Roche Diagnostics, Mannheim, Germany). Primers and universal probes were designed by the Universal Probe Library (Roche Diagnostics, Mannheim, Germany). The primer sequences of NUSAP1 were as follows: forward 5′-CTGTGCTTGGGACACAAA-3′; reverse 5′-TTGTCAACTTGAATGGGGTAATAA-3′. The primer sequences of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were as follows: forward 5′-CATCTCTGCCCCCTCTGCTGA-3′; reverse 5′-GGATGACCTTGCCCACAGCCT-3′. The reaction condition was 10 min at 95°C and 45 cycles of 10 s at 95°C, 30 s at 55°C, and 30 s at 72°C. Dissolution curve analysis was then performed. Each cell line was subjected to 3 independent repeated experiments.

Western blotting assay
----------------------

Cells in the logarithmic growth phase were selected, washed once with PBS, and lysed with 200 μL 1% sodium dodecyl sulfate (SDS) to extract fresh protein. The protein was quantified using the Pierce protein quantitation assay kit. We transferred 50--100 μg protein to polyvinylidene fluoride (PVDF) film after 12% SDS-PAGE gel separation and sealed it for 1 h with Tris-buffered saline-Tween 20 (TBST) containing with 5% milk. Then, the protein was incubated with anti-NUSAP1 antibody (ab93779; Abcam, Cambridge, MA, USA), anti-bcl-XL (ab32370; Abcam), anti-CDK1 (ab18; Abcam), and anti-DLGAP5 (ab84509; Abcam) overnight at 4°C or 2 h at room temperature, washed it 3 times with TBST (5 min each time), incubated it for 1.5 h with secondary antibody (Cell Signaling Technology, Inc) at room temperature, and rewashed it 3 times with TBST (10 min each time). β-actin was used as internal positive control. All Western blots shown are representative of at least 3 independent experiments.

Construction of overexpression vector
-------------------------------------

According to the sequence of the NUSAP1 gene, the primer sequence of its full-length cDNA was designed: forward 5′-GCG TTA CAG GCC CTT TGG CGC CTG-3′; reverse 5′-CGC AAT GTC CGG GAA ACC GCG GA-3′. The product was cloned into pCDH-CAM-MCS-EF1-CopGFP vector (YouBia company, Shanghai, China) to construct pCDH-CAM-MCS-EF1-CopGFP-NUSAP1. The positive overexpressed recombinant plasmid was sequenced by Berry Genomics Company and sequence alignment was carried out to screen successfully constructed overexpressed vector plasmid pCDH-CAM-MCS-EF1-CopGFP-NUSAP1.

Cell transfection
-----------------

pCDH-CAM-MCS-EF1-CopGFP-NUSAP1 was transfected into MCF-7 using Lipofectamine 3000, and empty vector was used as the control. Simultaneously, si-NUSAP1 and corresponding Scramble sequence were transiently transfected MCF-7. Two days after transfection, some cells showed green fluorescence and were selected in Dulbecco's modified Eagle's medium (DMEM) supplemented with 100 g/ml Amp and 400 μg/ml G418 to obtain stable strains of NUSAP1 overexpression, incubated in DMEM (10% FBS + P.S.), and cryopreserved.

MTT assay
---------

MCF-7 cells were made into single-cell suspension using medium with 10% FBS. A volume of 200 μL cell suspension was seeded into a 96-well plate, cultured for 24 h, then added with 10 μL MTT solution, and incubated for 4 h. We added 100 μL dimethylsulfoxide (DMSO) to each well and vibrated for 10 min of cell incubation at room temperature until the crystals were fully dissolved. Absorbance of each well was detected at 490 nm by enzyme-linked immunosorbent assay (ELISA). The result was recorded and a cell growth curve was drawn.

Transwell experiments
---------------------

Migration and invasion experiments were performed in a 24-well Transwell device with a 12.0-μm polycarbonate membrane. For the migration experiment, the polycarbonate membrane in the upper chamber was not covered by Matrigel, which was contrary to the invasion experiment. The specific operational method was based on published articles \[[@b13-medscimonit-24-8553]\]. The experimental installation for Transwell assay was purchased from Corning (Corning, NY, USA).

Cell cycle synchronization
--------------------------

To synchronize cells during the G0/G1 and G2/M transitions, MCF-7 cells were starved with 200 ng/ml nocodazole for 20 h or with serum for 48 h, then centrifuged and collected. Details are provided in previously published articles \[[@b14-medscimonit-24-8553],[@b15-medscimonit-24-8553]\].

Flow cytometry
--------------

To analyze the effect of NUSAP1 on the cell cycle, si-NUSAP1 cells, scramble cells, and MCF-7 cells were cultured to a density of 5×10^5^ cells/ml and processed using the CycleTEST Plus DNA kit (Becton-Dickinson, San Jose, CA, USA). Briefly, at room temperature, all cells were centrifuged for 5 min at 400 g, incubated with 250 ml solution A (trypsin buffer) for 10 min, then incubated with 200 ml solution B (trypsin inhibitor and RNase) for 10 min, and incubated with 200 ml solution C (propidium iodide, PI) for 10 min in the dark. DNA content was determined using FACSCalibur (Becton-Dickinson) by flow cytometry. The percentage of cells in phase G2-M was analyzed using FlowJo software (Tree Star, Ashland, OR, USA). To investigate the roles of NUSAP1 in cell apoptosis, the experiments were carried out using the FITC Annexin V kit (BD Bioscience, CA, USA). The synchronized cells were cultured for 24 h, centrifuged for 5 min at 2000 rpm, rinsed twice with precooled PBS, suspended into a density of 5×10^5^ cells/ml with 400 μL binding buffer, kept in the dark at 2--8°C after adding 5 μL Annexin V-EGFP for 15 min of culture, and then adding 10 μL PI for 5 min of culture. Subsequently, flow cytometry was used for cell counting.

Statistical analysis
--------------------

Measurement data are expressed as mean ± standard deviation (SD) and were analyzed by *t* test. The SD lines represent 3 independent repeated experiments. \<0.05 indicates statistically significant differences. All graphs were drawn using GraphPad Pism7.

Results
=======

Network-based meta-analysis
---------------------------

The data before and after treatment were analyzed and compared to screen out differentially expressed genes (DEGs). In brief, the conversion tool of Network Meta-analyst was used as the probe ID in chip data, and the corresponding platform was selected to convert the corresponding gene name. After probe matching, data were normalized using log2 conversion. Genes with adj p\<0.01 and absolute value of log FC \>1.5 were selected as DEGs (details of genes are provided in [Supplementary Table 1](#s1-medscimonit-24-8553){ref-type="supplementary-material"}).

Known IBC-related genes
-----------------------

IBC-related genes were downloaded from the ../../../../Documents/tencent files/1002826528/filerecv/the database for subsequent analysis and are shown in [Supplementary Table 2](#s2-medscimonit-24-8553){ref-type="supplementary-material"}.

Interaction network of DEGs
---------------------------

The correlation between common research IBC genes and DEGs was identified using STRING ([Figure 1](#f1-medscimonit-24-8553){ref-type="fig"}), in which there were 355 links. Through reviewing the literature, NUSAP1 was selected for the following experiments.

NUSAP1 was upregulated in IBC tissues and cells
-----------------------------------------------

T assess the NUSAP1 level in IBC, q-PCR and Western blotting assay was used for detecting the NUSAP1 level in IBC tissues and cells. The results showed that NUSAP1 presented higher expression in IBC tissues compared with the adjacent tissues. In cells, it was also upregulated in the breast cancer invasion cell lines compared with the normal human breast cell line (p\<0.05; p\<0.01; p\<0.001) ([Figure 2](#f2-medscimonit-24-8553){ref-type="fig"}).

Effect of NUSAP1 on the proliferation of MCF-7 cells
----------------------------------------------------

To investigate the role of NUSAP1 in IBC, we overexpressed or knocked down the expression of NUSAP1, and transfected it into MCF-7 cells. MTT and flow cytometry assays were performed to detected cell proliferation. The MTT assay results revealed that, from the 4th day of incubation, compared with empty vector-transfected cancer cells and non-transfected cancer cells, the number of cancer cells with NUSAP1 overexpression was slightly increased, as was cell proliferation ([Figure 3A](#f3-medscimonit-24-8553){ref-type="fig"}). Compared with the control group, the number of MCF-7 cells was notably decreased after NUSAP1 inhibition, in a time-dependent manner (p\<0.05) ([Figure 3B](#f3-medscimonit-24-8553){ref-type="fig"}). Flow cytometry data showed that the percentage of si-NUSAP1 cells in phase G2/M (30.5%) was higher than that of scramble cells (20.8%) in phase G2/M ([Figure 4A, 4B](#f4-medscimonit-24-8553){ref-type="fig"}). Western blot showed that CDK1 and DLGAP5 was downregulated by si-NUSAP1 ([Figure 4C, 4D](#f4-medscimonit-24-8553){ref-type="fig"}). These results suggest that downregulation of NUSAP1 inhibited growth of MCF-7 cells.

Effect of NUSAP1 on the migration and invasion of MCF-7 cells
-------------------------------------------------------------

To investigate the effect of NUSAP1 on IBC cell migration and invasion, cell migration and invasion assays were performed. In Transwell experiments, cell migration and invasion were increased in MCF-7 cells with NUSAP1 overexpression compared with the MCF-7 cells transfected with empty vector (p\<0.05; p\<0.01) and were obviously decreased in si-NUSAP1 cells compared with scramble cells (p\<0.05; p\<0.01) ([Figure 5](#f5-medscimonit-24-8553){ref-type="fig"}).

Inhibition of NUSAP1 expression remission epirubicin (E-ADM) resistance of MCF-7 cells
--------------------------------------------------------------------------------------

To assess the role of NUSAP1 in regulation E-ADM resistance, MTT assay was used to detected the survival rate of different E-ADMs (0.1--40 μM). MTT results showed that silencing NUSAP1 significantly inhibited cell growth and decreased IC50 value (si-NUSAP1 *vs.* control: 7.391 μM *vs.* 4.189 μM) ([Figure 6A, 6B](#f6-medscimonit-24-8553){ref-type="fig"}), which indicated that NUSAP1 reversed E-ADM resistance of MCF-7 cells. To further investigate the mechanism of NUSAP1 remission E-ADM resistance in MCF-7 cells, flow cytometry assay was performed in NUSAP1 silencing of MCF-7 cells with or without exposure to E-ADM ([Figure 6C](#f6-medscimonit-24-8553){ref-type="fig"}). Downregulating NUSAP1 dramatically promoted cell apoptosis in MCF-7 cells compared to control groups ([Figure 6D](#f6-medscimonit-24-8553){ref-type="fig"}, p\<0.05; p\<0.01) and the apoptosis rate further increased significantly in si-NUSAP1 cells treated with E-ADM ([Figure 6D](#f6-medscimonit-24-8553){ref-type="fig"}, p\<0.001). In contrast, downregulation of NUSAP1 dramatically inhibited the protein expression of bcl-XL in MCF-7 cells with or without expose to E-ADM ([Figure 6E, 6F](#f6-medscimonit-24-8553){ref-type="fig"}, p\<0.001), indicating that NUSAP1 inhibition improved the sensitivity of MCF-7 cells to E-ADM.

Discussion
==========

Using molecular biology techniques to study the molecular mechanism of cancer has become a strong trend in cancer research. Before clinical verification, bioinformatics can be used to find and screen DEGs associated with tumorigenesis. Much related research work has focused on the extraction and classification of gene expression data by means of gene differential expression analysis. In 1999, cancers were first classified by monitoring gene expression based on DNA microarray, and a general strategy for the discovery and prediction of cancer classification for other types of cancer was proposed \[[@b16-medscimonit-24-8553]\]. Since then, scientists have been able to mine potentially important genes in cancer by comparing the gene expression profiles of cancerous tissues and normal tissues. However, this approach is difficult to use for screening genes that play an important role in tumor expression, so meta-analysis is used to compare and evaluate the intersection of specific gene expression datasets for many cancers and to screen cancer-related genes \[[@b17-medscimonit-24-8553]\]. In the present study, we screened the IBC-related gene NUSAP1 based on bioinformatics methods, and a PPI data network map between the DEGs from the GEO database and IBC-related genes from PolySearch 2.0 was constructed using analysis tools in STRING. The results demonstrated that, except for SCN4B, BIRC5, NUSAP1, and CDCA8, all genes were in this map and directly interacted with the IBC hot gene MKI67. Through reviewing relevant documents, NUSAP1 was selected as the study gene in subsequent experiments.

NUSAP1 is a 55-KD vertebrate protein that plays a key role in spindle assembly and normal cell cycle progression and has been shown to interact directly with microtubules \[[@b18-medscimonit-24-8553]\]. NUSAP1 was first found in the study of melanoma, and identified to be pertinent to cell proliferation \[[@b10-medscimonit-24-8553],[@b11-medscimonit-24-8553]\]. After that, NUSAP1 gradually became the focus in various tumor research. Brinkley found that spindle defects lead to genomic instability in invasive tumor cells with NUSAP1 loss \[[@b19-medscimonit-24-8553]\]. Raemaekers found that NUSAP1 is localized in the nucleus and spindle and is over-expressed in proliferating cells in phase G2/M, resulting in spindle bundle bundling and inhibiting cell proliferation \[[@b18-medscimonit-24-8553]\]. In 2011, NUSAP1 was identified as an overexpression marker gene in invasive carcinomas and was predicted as a new tumor marker (*20*). Other studies have revealed that high expression of the NUSAP1 gene is associated with the movement of neural crest cells and the invasion characteristics of prostate cancer cells in zebrafish \[[@b7-medscimonit-24-8553],[@b21-medscimonit-24-8553]\]. Catherine found that NUSAP1 was beneficial for prostate cancer cell invasion and migration \[[@b22-medscimonit-24-8553]\]. Through protein-protein interaction (PPI) network analysis, we found that NUSAP1 can interact with CDK1 and DLGAP5. In eukaryotes, the decreased CDK1 correlates with G2/M phase accumulation \[[@b23-medscimonit-24-8553]\]. He et al. showed that knockdown of UBAP2L induces G2/M phase arrest in breast cancer cells by decreasing the expression of CDK1 \[[@b24-medscimonit-24-8553]\]. DLGAP5 is a novel cell cycle-regulated gene that can inhibit the proliferation and invasion of hepatocellular carcinoma cells \[[@b25-medscimonit-24-8553]\], but its function in breast cancer cells is not clear.

The present study found that expression of the NUSAP1 gene in cancer tissues of IBC patients was remarkably higher than that in adjacent tissues, and knockdown of NUSAP1 inhibited the expression of CDK1 and DLGAP5. The migration and invasion ability of the IBC cell line was enhanced by NUSAP1 overexpression but was significantly reduced by NUSAP1 inhibition, indicating that NUSAP1 expression facilitates the migration and invasion of IBC cells. Many reports have shown a correlation between NUSAP1 overexpression and cell proliferation, cycle, invasion, and migration.

With the increasing number of women developing breast cancer worldwide, and more than 1 million of women dying from breast cancer each year, neoadjuvant chemotherapy is very important. In clinical practice, anthracyclines (such as epirubicin) and taxanes (such as docetaxel), combined with other drugs, were used for the treatment of breast cancer. For instance, patients with lymph-node-positive breast cancer take docetaxel after combined use of doxorubicin and cyclic ammonium phosphate \[[@b26-medscimonit-24-8553]\], and patients with triple-negative breast cancer were treated by epirubicin combined with docetaxel \[[@b27-medscimonit-24-8553]\]. The combined effect of taxane and Herceptin treatment is used for breast cancer therapy induced by the overexpression of HER2 \[[@b28-medscimonit-24-8553]--[@b31-medscimonit-24-8553]\]. Our investigation found that inhibition of the NUSAP1 gene significantly inhibited MCF-7 cell proliferation, migration, and invasion, and epirubicin treatment enhanced cell apoptosis. We conclude that therapy targeting the NUSAP1 gene is important for neoadjuvant chemotherapy in IBC.

Conclusions
===========

In conclusion, this study confirmed that knockdown of NUSAP1 inhibited proliferation, migration, and invasion of IBC cells and enhanced the chemosensitivity of IBC cells to epirubicin by inhibiting the expression of CDK1 and DLGAP5.

Supplementary Tables
====================

###### 

List of detailed genes selected by network-based meta-analysis in the study.

  Name       Name       Name       Name           Name           Name
  ---------- ---------- ---------- -------------- -------------- ----------
  IGF1       IGFBP4     OLFML3     ZBTB16         COPZ2          KERA
  C19orf80   SLC2A4     ATP1B2     FAM72D         ENPP2          C2orf40
  VWF        OAF        MRAP       CDK1           FOXM1          TNIP3
  COL14A1    FBLN1      EXO1       PTTG2          DGAT2          HJURP
  NCAPH      MMP23B     OIP5       CCL20          KIF4A          C3
  PPAP2A     LPL        PLIN1      IL33           KL             RRAD
  SDPR       KIF11      HAPLN1     PLK1           EPHX1          DMRT2
  CD36       AKAP12     RAD51      PBK            CXCL14         ATOH8
  FXYD1      SCRN2      AOC3       SPAG5          PDGFRL         TUSC5
  GDF10      LAMA2      C15orf42   MME            KCNB1          CLDN19
  RAD54L     SFRP4      C1QTNF7    MMRN1          RDH5           AQP7P2
  UHRF1      MCM10      CMA1       ABLIM3         MAOA           GSTM2
  TNNT3      DARC       F10        PCOLCE         CA4            TPX2
  KIF23      PRC1       ESCO2      HIST1H1B       G0S2           CCNA2
  FAM64A     CD300LG    CES1       TSHZ2          ELTD1          TSC22D3
  TGFBR3     ALDH1A1    TFPI       SAMD5          CA3            NUSAP1
  PDE2A      LEP        PTTG1      C16orf89       MMP11          TMEM100
  ITIH5      JAM2       C1QTNF9B   LUZP2          TIMP4          FAM83D
  FHL1       MEOX2      CENPA      ACACB          APOD           SERPING1
  AKR1C3     ROBO4      PHYHIP     CAV2           ELN            EMX2
  CEP55      LDB2       GSC        PODN           PTN            FLNC
  TROAP      THRSP      RPSA       NNAT           CAMK1          PDLIM1
  DLGAP5     C16orf59   RERGL      MMP1           FREM1          PCK1
  HRC        CDCA8      ZWINT      CFD            PAMR1          CYP4F22
  CDCA5      BLM        RBP4       CENPE          AKR1C1         FIGF
  IGFBP6     PPARG      CKS2       OMD            HOXA5          1-Mar
  TK1        CD34       SEMA3G     CKMT2          ERCC6L         DEPDC1B
  TSPAN7     VWCE       DEPDC1     ANGPTL1        HABP4          CCDC8
  ASPM       RDM1       CYGB       PID1           ZNF695         ART5
  GPC3       DPT        CPZ        AGPAT2         ITGA7          NMU
  E2F1       FAM54A     OGN        HSPB7          PPP1R1A        LHX2
  POLQ       MATN2      SCN2B      NPR1           FABP4          MYOM2
  CLDN5      PLIN4      ASPA       NDN            ACADS          SOX11
  HMMR       FANCA      ABCA8      LOC100128164   RARRES2        CFHR4
  KIF2C      NGFR       SLIT2      KIFC1          MYZAP          TREM1
  CDKN1C     MAB21L1    PTH1R      PDGFD          GIMAP7         TTK
  EMCN       CIDEC      MFAP4      LRRC17         MMP2           LGALS12
  EZH2       NEK2       BMX        MYOC           GAS6           PDZRN3
  IL11RA     OSR1       H19        MEOX1          MELK           ANGPTL7
  HSPA12B    C7         MAMDC2     CDH5           MYH11          MYRIP
  FLRT2      RNASE4     RHOJ       CENPF          DAAM2          CITED1
  BTNL9      TNMD       C4orf49    C1orf115       BOC            CDKN3
  SGOL1      SKA3       VIPR2      C5orf46        CMTM5          TCEA2
  CLEC14A    EBF1       CLEC3B     EBF3           DENND2A        HLF
  CCDC80     CDO1       CIDECP     GPX3           TPO            BCHE
  DTL        ABCA9      DIO3OS     OLR1           CRTAC1         MIR143HG
  SLC25A18   ITM2A      E2F8       CDC25C         EDN3           ANLN
  BIRC5      SHE        RAMP3      MYBL2          TPSAB1         MMP12
  ADIPOQ     IL1B       E2F7       C18orf34       HAMP           PEBP4
  GPD1       GUCA2B     SPC25      GPIHBP1        LOC572558      LYVE1
  CAV1       PYGM       GSTM5      PCDH12         LOC100507537   ANKRD29
  NCAPG      ADH1A      ABCB1      KIF18A         IGF2           4-Sep
  GPAM       ZCCHC24    SRPX       CDCA2          RSPO3          GTSE1
  UBE2C      ADH1C      AVPR2      CKAP2L         FGF2           PLP1
  SCN4B      PKMYT1     SELP       CPXM1          TF             KIF20A
  CDC45      UBE2T      DNASE1L3   CDCA3          SFRP2          BUB1

###### 

IBC-related genes were downloaded from the../../../../Documents/tencent files/1002826528/filerecv/the database.

  Name    Name
  ------- -------
  ERBB2   CD324
  EGFR    GFRP1
  ESR1    PPIG
  NR3C3   RAD1
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![Protein-protein interaction network of IBC genes and DEGs. IBC-related genes were downloaded from PolySearch 2.0. Differentially expressed genes (DEGs) were screened from Network-based meta-analysis.](medscimonit-24-8553-g001){#f1-medscimonit-24-8553}

![Expression of NUSAP1 in IBC clinical samples and breast cancer cells. (**A**) NUSAP1 presented high expression in IBC tissues compared with the adjacent tissues (*P*\<0.001). (**B**) Expression of NUSAP1 was significantly higher in the 4 breast cancer cell lines compared with the normal Hs578Bst cell line (p\<0.05, p\<0.01). \* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001. (**C**) Western blot analysis of expression of NUSAP1 in different breast cancer cell lines. (**D**) The bar chart below demonstrates the ratio of NUSAP1 protein to β-actin by densitometry in breast cancer cells. The data are mean ±SEM (\* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001 compared with control).](medscimonit-24-8553-g002){#f2-medscimonit-24-8553}

![Effect of NUSAP1 on the proliferation of MCF-7 cells. MTT was used to detect the proliferation of cells. (**A**) Effect of NUSAP1 overexpression on the proliferation of MCF-7 cells. The number of cancer cells with NUSAP1 overexpression was slightly increased but did not reach a significant level. (**B**) Effect of si-NUSAP1 on the proliferation of MCF-7 cells. After inhibition of NUSAP1 expression, the number of MCF-7 cells was significantly decreased compared with the control group.](medscimonit-24-8553-g003){#f3-medscimonit-24-8553}

![NUSAP1 knockdown blocked cell cycle by suppressing the expression of CDK1 and DLGAP5. (**A, B**) Flow cytometry data showed that more cells were retarded in G2/M phase after 48-h transfection and the percentage of si-NUSAP1 cells in phase G2/M (26.4%) was higher than that of scramble cells (15.5%) in phase G2/M. (**C**) Western blot showed downregulated protein expression of CDK1 and DLGAP5. (**D**) The bar chart below demonstrates the ratio of CDK1 or DLGAP5 protein to β-actin by densitometry with or without NUSAP1 shRNA transfection. The data are mean ±SEM (\* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001). (**E**) Protein-protein interaction network of NUSAP1.](medscimonit-24-8553-g004){#f4-medscimonit-24-8553}

![Effect of NUSAP1 on the migration and invasion of MCF-7 cells. (**A**) Images and statistical results from the Transwell migration and invasion assays of NUSAP1 overexpression MCF-7 cells (×100). (**B**) Images and statistical results from the Transwell migration and invasion assays of si-NUSAP1 MCF-7 cells (×100). \* p\<0.05; \*\* p\<0.01.](medscimonit-24-8553-g005){#f5-medscimonit-24-8553}

![Inhibition of NUSAP1 expression and E-ADM process promoted the apoptosis of MCF-7. (**A**) MTT assay was performed in scramble and NUSAP1 silencing cells exposed to E-ADM (0.1, 0.5, 1, 5, 10, 20, 40 μM). (**B**) IC50 value of E-ADM in MCF-7 cells with or without NUSAP1 silencing. (**C**) Annexin V-FITC/PI was used to detect the apoptosis of cells by flow cytometry. (**D**) Statistical results of total apoptosis rate were analyzed from 3 times experiments. Cell apoptosis rate=UR+LR. \*p\<0.05; \*\*p\<0.01. (**E**) Western blot showed downregulated protein expression of bcl-XL with or without E-ADM treatment and NUSAP1 shRNA transfection. (**F**) The bar chart below demonstrates the ratio of bal-Xl protein to β-actin by densitometry with or without E-ADM treatment and NUSAP1 shRNA transfection. The data are mean ±SEM (\* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001).](medscimonit-24-8553-g006){#f6-medscimonit-24-8553}
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